Is tacrolimus effective for treating antisynthetase-associated interstitial lung disease?
Bongartz
Tim
T
Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA. bongartz.tim@mayo.edu
Ryu
Jay H
JH
Matteson
Eric L
EL
D000604:Amino Acyl-tRNA Synthetases / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D017563:Lung Diseases, Interstitial / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D011653:Pulmonary Diffusing Capacity / Q000502:physiology; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*; D016896:Treatment Outcome
D001323:Autoantibodies; D007166:Immunosuppressive Agents; D000604:Amino Acyl-tRNA Synthetases; D016559:Tacrolimus